Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 0 | 0 | 0 | 859 |
| Gross Profit | N/A | N/A | N/A | N/A | 859 |
| Operating Expenses | 42,354 | 36,021 | 36,516 | 32,303 | 42,302 |
| Operating Income | -42,354 | -36,021 | -36,516 | -32,303 | -41,443 |
| Other Income | 3,894 | 2,296 | 2,322 | 1,071 | 406 |
| Pre-tax Income | -38,460 | -33,725 | -34,194 | -31,232 | -41,037 |
| Net Income Continuous | -38,460 | -33,725 | -34,194 | -31,232 | -41,037 |
| Net Income | $-38,460 | $-33,725 | $-34,194 | $-31,232 | $-41,037 |
| EPS Basic Total Ops | -0.68 | -0.67 | -0.69 | -0.64 | -0.84 |
| EPS Basic Continuous Ops | -0.68 | -0.67 | -0.70 | -0.64 | -0.84 |
| EPS Diluted Total Ops | -0.68 | -0.67 | -0.69 | -0.64 | -0.84 |
| EPS Diluted Continuous Ops | -0.68 | -0.67 | -0.70 | -0.64 | -0.84 |
| EBITDA(a) | $-42,493 | $-36,444 | $-36,590 | $-31,539 | $-40,504 |